Dividends & Buybacks ·
Quince Therapeutics, Inc. has implemented a 1-for-20 reverse stock split, which became effective at 11:59 pm ET on…
QNCXIRulya Therapeutics Inc.
Quince Therapeutics, Inc. has implemented a 1-for-20 reverse stock split, which became effective at 11:59 pm ET on June 29, 2026, reducing the total outstanding shares from 19,559,257 to approximately 977,963. Shares will begin trading on a split-adjusted basis on the Nasdaq Global Select Market on June 30, 2026. Quince Therapeutics, Inc. is a biotechnology company focused on developing therapeutic solutions for rare diseases.